|
|
| Discussions for Wyeth | View all discussions |
|
| Wyeth and Merck May See Increased Orders for their Pneumonia Vaccines this Flu Season | ||
| Only 1 message in discussion - | ||
From: Public Health <drplum...@gmail.com>
Date: Fri, 9 Oct 2009 07:40:24 -0700 (PDT)
Local: Fri, Oct 9 2009 10:40 am
Subject: Wyeth and Merck May See Increased Orders for their Pneumonia Vaccines this Flu Season
A significant amount of the hospitalizations and deaths associated
with an initial influenza infections are due to secondary pneumonias that develop during the course or an individual attempting to fight the flu. One way to protect against a common cause of secondary pneumonia, Streptococcus pneumoniae is with a the PPSV23 a pneumonia vaccine. It specifically protects against Sthe bacteria Streptococcus pneumoniae. The only companies that I am aware of that market this particular type of vaccine is the US is Wyeth and Merck. Apparantly cases are increasing and public health officials are urging that at a minimum high risk individuals be vaccinated. As the article attached reads "All children under 5 should receive the
Streptoccocus pneumoniae is not the on culprit that can cause
http://www.msnbc.msn.com/id/33088461/ns/health-swine_flu/
http://www.webmd.com/cold-and-flu/news/20090930/bacteria-have-role-in...
http://www.mcknights.com/CDC-recommends-pneumonia-vaccine-and-flu-vac...
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
| ||||||||||||||
| End of messages |
| No newer discussions | Timeline for the merger - Older discussion » |
| Google Home - Terms of Service - Privacy Policy |
©2009 Google